[4] Under Merck & Co., Schering-Plough imported the product line from China[5] and had a North American distribution agreement for footwear with the Brown Shoe Company (now Caleres).

Bayer bought Dr. Scholl's in 2014 as part of its acquisition of Merck & Co's consumer health unit.

[8] In July 2019, Bayer sold Dr. Scholl's to Yellow Wood Partners for $585 million.

[6] In 1984, Schering-Plough sold the global brand and non-North American operations to European Home Products (later SSL International), who manufactured and distributed footwear and foot care products under the Scholl brand.

[10] In 2014, Aurelius, a German private equity firm, purchased the international rights to Scholl Footwear from Reckitt Benckiser, excluding the Americas.